IsoRay (ISR) Reports Prelim. Q2 Revenue of $1.54M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to IsoRay (ISR) Reports Prelim. Q2 Revenue of $1.54M

IsoRay Announces Preliminary Second Quarter F2018 Revenue of $1.54 Million, 50% Year-over-Year Increase

January 24, 2018 8:01 AM EST

RICHLAND, Wash, Jan. 24, 2018 (GLOBE NEWSWIRE) --  -- IsoRay, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, today announced preliminary unaudited revenue and gross profit results for the second quarter of fiscal 2018 ended December 31, 2017.

Preliminary revenue and gross profit for the second quarter of fiscal 2018:

Preliminary revenue for the three months ended December 31,... More